Batalla, A., Suh‐Oh, H. J., Carretero Hernández, G., Miquel Miquel, J., Botella Estrada, R., Martorell Calatayud, A., . . . Flórez, A. (2023). Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis.
Citación estilo ChicagoBatalla, Ana, Hae Jin Suh‐Oh, Gregorio Carretero Hernández, Javier Miquel Miquel, Rafael Botella Estrada, Antonio Martorell Calatayud, Virginia Sanz Motilva, Ignasi Figueras Nart, y Angeles Flórez. Observational 24‐week Study to Assess Clinical Response to Upadacitinib Posttrial in Patients With Moderate‐to‐severe Atopic Dermatitis. 2023.
Cita MLABatalla, Ana, et al. Observational 24‐week Study to Assess Clinical Response to Upadacitinib Posttrial in Patients With Moderate‐to‐severe Atopic Dermatitis. 2023.